Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – Here’s Why

Shares of Elekta AB (OTCMKTS:EKTAY) saw unusually-high trading volume on Wednesday . Approximately 1,069 shares changed hands during mid-day trading, an increase of 328% from the previous session’s volume of 250 shares.The stock last traded at $6.27 and had previously closed at $6.15.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 16th. Three analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce”.

Elekta Price Performance

The stock has a market cap of $2.38 billion, a P/E ratio of 21.79 and a beta of 1.04. The company has a current ratio of 1.04, a quick ratio of 0.79 and a debt-to-equity ratio of 0.66. The company’s fifty day simple moving average is $5.54 and its 200-day simple moving average is $5.21.

Elekta (OTCMKTS:EKTAY) last issued its earnings results on Wednesday, November 26th. The company reported $0.07 earnings per share for the quarter. Elekta had a net margin of 1.62% and a return on equity of 12.14%. The business had revenue of $427.85 million for the quarter, compared to analyst estimates of $436.91 million. As a group, sell-side analysts forecast that Elekta AB will post 0.36 EPS for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.